OncoSpherix’s CEO will Give Keynote Address at Drug Discovery Nexus East Coast 2022 on April 21, 2022

by Oncospherix | Apr 20, 2022 | General

Dr. Margaret K Offermann will be speaking on Thursday, April 21, 2022 from 11:30 AM -12:00 PM Eastern time at the Drug Discovery Nexus East Coast 2022 conference that will be held virtually.  The title of her presentation is “Improving Design and Interpretation...

Oncospherix’s Chief Scientific Officer Dr. Erwin Van Meir Publishes Study that Sheds Light on HIF-Regulated Genes that Contribute to Tumor Invasion and Metastasis in Eye Melanoma

by Oncospherix | Mar 4, 2022 | General

Dr. Erwin Van Meir and colleagues published a study identifying HIF-regulated genes (P4HA1 and P4HA2) that contribute to the invasion of uveal melanoma cells into surrounding tissues. Importantly, this process could be blocked using a HIF inhibitor, KCN1, that works...

OncoSpherix’s Founding Scientist and Board of Directors’ member Binghe Wang, PhD, is Honored by his Selection as a National Academy of Inventors Fellow

by Oncospherix | Feb 28, 2022 | General

OncoSpherix is pleased to announce that Dr. Binghe Wang has been elected as a fellow at the National Academy of Inventors. Dr. Wang is a renowned synthetic medicinal chemist with expertise in drug design, delivery, and molecular recognition. He is a founding scientist...

OncoSpherix’s CEO Keynote Speaker at Meridian Drug Discovery Virtual Conference

by Oncospherix | Nov 17, 2021 | General

OncoSpherix’s CEO, Margaret K Offermann, MD, PhD, is a keynote speaker at the 3rd Meridian Drug Discovery Virtual Conference on November 19, 2021. She will be presenting an update on the science of OncoSpherix, with special focus on the chemistry of their clinical...

OncoSpherix Shares Insights in Biolocity’s “Tales from the Trenches” Panel

by Oncospherix | Nov 11, 2021 | General

OncoSpherix’s CEO, Margaret “Kenny” Offermann, will be a panelist in Biolocity’s  Bench to Market series as part of a panel presenting “Tales from the Trenches” on Wednesday, Nov 17, 2021 at 11:30 AM Eastern Time. Attendance is free following registration at:...